a
Gesamtsumme
Impact Factor
= 180,662
Behringer
W, Kittler
H, Sterz F, Domanovits H, Schoerkhuber W,
Holzer M, Mullner M, Laggner AN: Cumulative
epinephrine dose during cardiopulmonary
resuscitation and neurologic outcome.
Ann.Intern.Med. 1998; 129:450-456
T, IF = 12,047
Binder M, Kittler H, Seeber A, Steiner A, Pehamberger H, Wolff K:
Epiluminescence microscopy-based
classification of pigmented skin lesions using
computerized image analysis and an artificial
neural network. Melanoma Research 1998;
8:261-266
T, IF = 1,596
Binder M, Steiner A, Mossbacher
U, Hunegnaw M, Pehamberger
H, Wolff K: Estimation of the
volume-weighted mean nuclear volume
discriminates keratoacanthoma from squamous
cell carcinoma. Amer J Dermatopathol. 1998;
20: 453-458
S, IF = 0,805
Egorov
A, Brandt S, Sereinig S, Romanova J, Ferko B,
Katinger D, Grassauer A, Alexandrova G,
Katinger H, Muster
T: Transfectant influenza A viruses with
long deletions in the NS1 protein grow
efficiently in vero cells. J of Virology 1998,
72 (8): 6437-6441
T, IF = 5,821
Ferko
B, Katinger D, Grassauer A, Egorov A, Romanova
H, Katinger H, Muster
T: Chimeric influenza virus replicating
predominantly in the murine upper respiratory
tract induces local immune responses against
HIV-1 in the genital tract. J
Infect Dis 1998, 178: 1359-1369.
T, IF = 5,099
Födinger D, Elbe-Bürger A, Sterniczky
B, Lackner M, Horvat R, Wolff
K, Rappersberger
K: Erythema multiforme associated human
autoantibodies against desmoplakin I and II:
Biochemical characterization and passive
transfer studies into newborn mice.
J Invest Dermatol 1998; 111:503-510
T, IF = 4,584
Garcia-Sastre
A, Egotov A, Matassov D, Brand
S, Levy E, Durbin J.E., Palese P, Muster
T: Influenza A virus lacking the NS1 gene
replicates in interferon-deficient systems.
Virology
1998, 252: 324-330
T, IF = 3,540
Gröchenig
E, Albegger K, Dietrich HJ, Frankie PR,
Gerlach E, Jurecka W, Kiesewetter H, Kjoch G, Ladurner G, Pölz W, Schimetta W,
Schneeberger R, Volgger R, Wilhelm HJ, Zelger
J: Hydroxyethylstarch-related pruritus: a
progressive multicenter investigation of SLL
patients. Perfusion, 1998, 11:62-69
S, IF = 0,534
Gruber
DM, Sator MO, Joura EA, Kokoschka
EM, Heinze G, Huber JC: Topical
cyproterine acetate treatment in women with
acne. Arch Dermatol 1998, 134: 459-463
T, IF = 2,358
Gschwandtner
M, Ambrozy E, Böhler
K, Fasching S, Gaggl
U, Schneider B, Ehringer H:
Reproducibility of laser Doppler imager flux
measurements within ischemic or venous ulcers
and adjacent skin. Skin Research and
Technology 1998, 4: 222-227
kein IF
Herneth
AM, Pokieser P, Kettenbach J, Rappersberger
K, Mostbeck G: Pneumatosis intestinalis in
AIDS-associated chronic intestinal
cryptosporidiosis: a benign course in a
severe-looking disease. Eur Radiol 8 (8):
1499, 1998
S, IF: 0,561
Jansen B, Schlagbauer-Wadl H, Brown BD, Bryan RN, van EA, Müller M, Wolff
K, Pehamberger H: Bcl-2 antisense therapy chemosensitizes human
melanoma in SCID mice.
Nature
Medicine 1998; 4:232-234
T, IF = 28,114
Jurecka
W: Befunde
zur Speicherung künstlicher Kolloide beim
Menschen. Anästhesiologie, Intensivmedizin,
Notfallmedizin, Schmerztherapie 1998, 33:
264-265
IF = 0,69
Kittler H, Seltenheim M, Pehamberger
H, Wolff K, Binder M: Diagnostic
informativeness of compressed digital
epiluminescence microscopy images of pigmented
skin lesions compared with photographs.
Melanoma Research 1998; 8:255-260
T, IF = 1,596
Kunstfeld R,
Lechleitner
S, Wolff K, Petzelbauer P: MCP-1 and MIP-a-alpha are most efficient in
recruiting T cells into the skin in vivo and
their function is endothelial cell-dependent.
J Invest Dermatol, 1998; 111: 1040-1044
T, IF = 4,584
Lechleitner S,
Gille J, Johnson DR, Petzelbauer
P: Interferon enhances tumor necrosis
factor-induced vascular cell adhesion molecule
1 (CD106) expression in human endothelial
cells by an interferon-related factor
1-dependent pathway. J Exp Med. 1998;
187:2023-2030
T, IF = 14,384
Maurer
D, Fiebiger E, Reininger B, Ebner C, Petzelbauer
P, Shi GP, Chapman HA, Stingl G: Fc
epsilon receptor I on dendritic cells delivers
IgE-bound multivalent antigens into a
cathepsin S-dependent pathway of MHC class II
presentation. J Immunol 1998; 161:2731-2739
T, IF = 6,937
Meghdadi
S, Karanikas G, Schlagbauer WH, Jansen
B, Chehne F, Rodrigues M, Pehamberger
H, Sinzinger H:
Technetium-99m-tetrofosmin: a new agent for
melanoma imaging?
Anticancer
Res. 1998; 18:2759-2762
S, IF = 1,045
Monney
L, Olivier R, Otter I, Jansen
B, Poirier GG, Borner C: Requirement of an
acidic cellular compartment for TNF-alpha
induced production of ceramide, activation of
the death protease caspase 3 and apoptosis. Eur. J. Biochem 1998, 251: 295-303
T, IF = 3,136
Obermair
A, Binder
M, Barrada M, BancherTodesca D, Asseryanis
E, Kubista E: Onycholysis in patients treated
with docetaxel. Annals of Oncology 1998;
9:230-231
S, IF = 2,548
Oehler
L, Majdic O, Pickl WF, Stockl J, Riedl E,
Drach J, Rappersberger K, Geissler K, Knapp W: Neutrophil
granulocyte-committed cells can be driven to
acquire dendritic cell characteristics.
J
Exp Med 1998, 187(7): 1019-1028
T, IF = 14,384
Osterode
W, Rudiger H, Graninger W, Petzl DH, Rappersberger
K, Dekan G, Weihs A, Graninger W: Anti-PL
12 and pulmonary fibrosis in a patient ten
years after silica/silicate dust exposure.
Clin
Exp Rheumatol 16 (5): 622, 1998
S , IF: = 1,152
Pehamberger H,
Soyer HP, Steiner A, Kofler R, Binder
M, Mischer P, Pachinger W, Auböck J,
Fritsch P, Kerl H, Wolff K: Adjuvant interferon alfa-2a treatment in resected primary
stage II cutaneous melanoma. Austrian
Malignant Melanoma Cooperative Group.
J.Clin.Oncol.
1998; 16:1425-1429
T, IF = 7,878
Petru
E, Nagele F, Czerwenka K, Graf AH, Lax S,
Bauer M, Pehamberger H, Vavra N: Primary malignant melanoma of the vagina:
Long-term remission following radiation
therapy.
Gynecological
Oncology 1998, 70: 23-26
S, IF = 1,542
Rehberger A, Püspok A, Stallmeister T, Jurecka W, Wolff
K: Crohn's disease masquerading as aphthous ulcers. Europ J
Dermatol. 1998; 8:274-276
S, IF = 0,460
Rosse
T, Olivier R, Monney L, Rager M, Conus S,
Fellay I, Jansen B, Borner C: Bcl-2 prolongs cell survival after Bax induced
cytochrome C release. Nature 1998, 391:
496-499
T, IF = 27,368
Sauter B, Födinger D, Sterniczky B, Wolff K, Rappersberger K: Immunoelectron
microscopic characterization of human dermal
lymphatic microvascular endothelial cells.
Differential expression of CD31, CD34, and
type IV collagen with lymphatic endothelial
cells vs blood capillary endothelial cells in
normal human skin, lymphangioma, and
hemangioma in situ.
J.Histochem.Cytochem. 1998; 46:165-176
S, IF = 2,776
Seidel
MG, Freissmuth M,
Pehamberger H, Micksche M: Stimulation of
natural killer activity in peripheral blood
lymphocytes of healthy donors and melanoma
patients in vitro: synergism between
interleukin (IL)-12 and IL-15 or IL-12 and
IL-2. Archives of Pharmacology, 1998, 358:
382-389
S, IF = 0,528
Schett
G, Redlich K, Xu Q, Bizan P, Gröger
M, Tohidast M, Kiener H, Smolen J, Steiner
G: Enhanced expression of heat shock protein
70 and heat shock factor 1 activation in
rheumatoid arthritis synovial tissue. J Clin
Investigation 1998, 102: 302-311
T, IF = 9,667
Schön
H, Födinger
D, Derfler K, Amann G, Rappersberger
K, Stingl G, Volc-Platzer B:
Immunoapheresis in paraneoplastic pemphigus.
Arch.Dermatol. 1998; 134:706-710
T, IF = 2,358
Schreiber
W, Woisetschlager C, Binder
M, Kaff A, Raab H, Hirschl MM: The nitura
study - effect of nitroglycerin or urapidil on
hemodynamic, metabolic and respiratory
parameters in hypertensive patients with
pulmonary edema. Intensive Care Medicine 1998;
24:557-563
T, IF = 1,685
Seeber H, Binder M, Wolff K, Pehamberger H: Treatment of metastatic malignant melanoma with dacarbazine plus
fotemustine. European Journal of Cancer 1998,
34: 2129-2131
S, IF = 2,407
Selzer
E, Schlagbauer-Wadl H, Okamoto I, Pehamberger
H, Pötter R, Jansen
B: Expression of Bcl-2 family members in
human melanocytes, in melanoma metastases and
in melanoma cell lines. Melanoma Research
1998; 8:197-203
T, IF = 1,596
Stallmeister T,
Dieckmann K, Rehberger
A, Jurecka W: Long-term remission of
tumor-stage mycosis fungoides following
total-skin electron-beam radiotherapy.
Europ
J Dermatol 1998; 8:240-242
S, IF = 0,460
Strohal
R, Brna C,
Mossbacher U, Fischer G,
Pehamberger H, Stingl G: First comparative
delineation of the T-cell receptor repertoire
in primary and multiple subsequent/coexisting
metastatic melanoma sites. J
Invest Dermatol 1998, 111: 1085-1091
T, IF = 4,584
Ure I, Partsch B, Wolff K, Petzelbauer P: Granulocyte/macrophage
colony-stimulating factor increases
wound-fluid interleukin 8 in normal subjects
but does not accelerate wound healing.
Br
J Dermatol. 1998; 138:277-282
T, IF = 1,838
|
